We use cookies to customise content for your subscription and for analytics.
If you continue to browse Lexology, we will assume that you are happy to receive all our cookies. For further information please read our Cookie Policy.
Lexology logo
  Request new password

Sharon L. Caffrey Duane Morris LLP

Results 1 to 5 of 26



Every breath theory: on its last breaths? *

USA - January 22 2013
The "every breath," or cumulative exposure opinion, has been proffered by plaintiffs' experts in asbestos cases to prove specific causation…

Co-authors: Alyson Walker Lotman, Erin M. Carter.


Third Circuit ruling affords defendants protection from amended complaints after statute of limitations runs out *

USA - September 10 2012
The U.S. Court of Appeals for the Third Circuit limited plaintiffs' ability to add claims to a complaint under the relation back provision of Federal Rule of Civil Procedure 15(c) in Glover v. FDIC, No. 11-3382 (Sept. 5, 2012).

Co-authors: Alyson Walker Lotman.


"Every breath" of asbestos is not a substantial factor in Pennsylvania *

USA - May 25 2012
The Pennsylvania Supreme Court unanimously found that plaintiffs cannot rely on the theory that "every breath" is a substantial contributing factor in causing an asbestos-related disease in an asbestos case involving friction exposures, i.e., brakes and clutches.

Co-authors: Robert L. Byer.


Fifth Circuit concludes that U.S. Supreme Court's "fraud-on-the-FDA" federal preemption precedent has broad application *

USA - March 2 2012
On February 22, 2012, the U.S. Court of Appeals for the Fifth Circuit unanimously affirmed the U.S. District Court for the Northern District of Texas' granting of a defendant drug manufacturer’s motion for summary judgment on all claims, including the plaintiffs' failure-to-warn claims, in Lofton v. McNeil Consumer & Specialty Pharmaceuticals, No. 10-10956, slip op. (5th Cir. Feb. 22, 2012).

Co-authors: Paul M. da Costa.


Two-disease rule no more: Pennsylvania allows multiple malignancy *

USA - February 24 2012
In a decision that impacts all asbestos defendants, the Pennsylvania Supreme Court held that the so-called "two-disease" rule allows plaintiffs in asbestos cases to file multiple malignancy claims.

Co-authors: Alyson B. Walker .


Next »